Hologic (HOLX) Competitors

Edwards Lifesciences (NYSE:EW) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Do institutionals & insiders hold more shares of EW or HOLX?

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 94.7% of Hologic shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by company insiders. Comparatively, 1.9% of Hologic shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has higher earnings & valuation, EW or HOLX?

Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.00B	7.18	$1.40B	$6.93	10.56
Hologic	$4.03B	4.04	$789.50M	$3.33	21.67

Do analysts rate EW or HOLX?

Edwards Lifesciences currently has a consensus price target of $79.19, indicating a potential upside of 8.26%. Hologic has a consensus price target of $88.92, indicating a potential upside of 23.21%. Given Hologic's stronger consensus rating and higher probable upside, analysts clearly believe Hologic is more favorable than Edwards Lifesciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	1 Sell rating(s)	13 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.42
Hologic	0 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.63

Which has more volatility & risk, EW or HOLX?

Edwards Lifesciences has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500.

Does the media refer more to EW or HOLX?

In the previous week, Edwards Lifesciences had 12 more articles in the media than Hologic. MarketBeat recorded 27 mentions for Edwards Lifesciences and 15 mentions for Hologic. Edwards Lifesciences' average media sentiment score of 0.99 beat Hologic's score of 0.39 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	17 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hologic	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is EW or HOLX more profitable?

Edwards Lifesciences has a net margin of 70.82% compared to Hologic's net margin of 19.59%. Edwards Lifesciences' return on equity of 20.76% beat Hologic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	70.82%	20.76%	15.27%
Hologic	19.59%	19.79%	11.00%

Does the MarketBeat Community believe in EW or HOLX?

Edwards Lifesciences received 457 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 71.01% of users gave Edwards Lifesciences an outperform vote while only 69.63% of users gave Hologic an outperform vote.

Company	Underperform	Outperform
Edwards Lifesciences	Outperform Votes 1335 71.01%	Underperform Votes 545 28.99%
Hologic	Outperform Votes 878 69.63%	Underperform Votes 383 30.37%

Summary

Edwards Lifesciences beats Hologic on 13 of the 19 factors compared between the two stocks.